These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 38718356)

  • 1. Striatin plays a major role in angiotensin II-induced cardiomyocyte and cardiac hypertrophy in mice in vivo.
    Cull JJ; Cooper STE; Alharbi HO; Chothani SP; Rackham OJL; Meijles DN; Dash PR; Kerkelä R; Ruparelia N; Sugden PH; Clerk A
    Clin Sci (Lond); 2024 May; 138(10):573-597. PubMed ID: 38718356
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Angiotensin II type-1 receptor activation in the adult heart causes blood pressure-independent hypertrophy and cardiac dysfunction.
    Ainscough JF; Drinkhill MJ; Sedo A; Turner NA; Brooke DA; Balmforth AJ; Ball SG
    Cardiovasc Res; 2009 Feb; 81(3):592-600. PubMed ID: 18703536
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FKBP12.6 protects heart from AngII-induced hypertrophy through inhibiting Ca
    Xiao YF; Zeng ZX; Guan XH; Wang LF; Wang CJ; Shi H; Shou W; Deng KY; Xin HB
    J Cell Mol Med; 2018 Jul; 22(7):3638-3651. PubMed ID: 29682889
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiac striatin interacts with caveolin-3 and calmodulin in a calcium sensitive manner and regulates cardiomyocyte spontaneous contraction rate.
    Nader M; Alotaibi S; Alsolme E; Khalil B; Abu-Zaid A; Alsomali R; Bakheet D; Dzimiri N
    Can J Physiol Pharmacol; 2017 Oct; 95(10):1306-1312. PubMed ID: 28825318
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stromal Cell-SLIT3/Cardiomyocyte-ROBO1 Axis Regulates Pressure Overload-Induced Cardiac Hypertrophy.
    Liu X; Li B; Wang S; Zhang E; Schultz M; Touma M; Monteiro Da Rocha A; Evans SM; Eichmann A; Herron T; Chen R; Xiong D; Jaworski A; Weiss S; Si MS
    Circ Res; 2024 Mar; 134(7):913-930. PubMed ID: 38414132
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dysferlin Enables Tubular Membrane Proliferation in Cardiac Hypertrophy.
    Paulke NJ; Fleischhacker C; Wegener JB; Riedemann GC; Cretu C; Mushtaq M; Zaremba N; Möbius W; Zühlke Y; Wedemeyer J; Liebmann L; Gorshkova AA; Kownatzki-Danger D; Wagner E; Kohl T; Wichmann C; Jahn O; Urlaub H; Toischer K; Hasenfuß G; Moser T; Preobraschenski J; Lenz C; Rog-Zielinska EA; Lehnart SE; Brandenburg S
    Circ Res; 2024 Aug; 135(5):554-574. PubMed ID: 39011635
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MG53, A Novel Regulator of KChIP2 and I
    Liu W; Wang G; Zhang C; Ding W; Cheng W; Luo Y; Wei C; Liu J
    Circulation; 2019 Apr; 139(18):2142-2156. PubMed ID: 30760025
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The alteration of protein prenylation induces cardiomyocyte hypertrophy through Rheb-mTORC1 signalling and leads to chronic heart failure.
    Xu N; Guan S; Chen Z; Yu Y; Xie J; Pan FY; Zhao NW; Liu L; Yang ZZ; Gao X; Xu B; Li CJ
    J Pathol; 2015 Apr; 235(5):672-85. PubMed ID: 25385233
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fibulin-2 deficiency attenuates angiotensin II-induced cardiac hypertrophy by reducing transforming growth factor-β signalling.
    Zhang H; Wu J; Dong H; Khan SA; Chu ML; Tsuda T
    Clin Sci (Lond); 2014 Feb; 126(4):275-88. PubMed ID: 23841699
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiomyocyte BRAF is a key signalling intermediate in cardiac hypertrophy in mice.
    Alharbi HO; Hardyman MA; Cull JJ; Markou T; Cooper STE; Glennon PE; Fuller SJ; Sugden PH; Clerk A
    Clin Sci (Lond); 2022 Nov; 136(22):1661-1681. PubMed ID: 36331065
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Suppressive Effects of Glucose-Dependent Insulinotropic Polypeptide on Cardiac Hypertrophy and Fibrosis in Angiotensin II-Infused Mouse Models.
    Hiromura M; Mori Y; Kohashi K; Terasaki M; Shinmura K; Negoro T; Kawashima H; Kogure M; Wachi T; Watanabe R; Sato K; Kushima H; Tomoyasu M; Nakano Y; Yamada Y; Watanabe T; Hirano T
    Circ J; 2016 Aug; 80(9):1988-97. PubMed ID: 27375170
    [TBL] [Abstract][Full Text] [Related]  

  • 12. STRIPAK complexes: structure, biological function, and involvement in human diseases.
    Hwang J; Pallas DC
    Int J Biochem Cell Biol; 2014 Feb; 47():118-48. PubMed ID: 24333164
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mnk1 (Mitogen-Activated Protein Kinase-Interacting Kinase 1) Deficiency Aggravates Cardiac Remodeling in Mice.
    Yuan Y; Yan L; Wu QQ; Zhou H; Jin YG; Bian ZY; Deng W; Yang Z; Shen DF; Zeng XF; Wang SS; Li H; Tang QZ
    Hypertension; 2016 Dec; 68(6):1393-1399. PubMed ID: 27698061
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overexpressed connective tissue growth factor in cardiomyocytes attenuates left ventricular remodeling induced by angiotensin II perfusion.
    Zhang Y; Yan H; Guang GC; Deng ZR
    Clin Exp Hypertens; 2017; 39(2):168-174. PubMed ID: 28287886
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gene expression profiling of hypertrophic cardiomyocytes identifies new players in pathological remodelling.
    Vigil-Garcia M; Demkes CJ; Eding JEC; Versteeg D; de Ruiter H; Perini I; Kooijman L; Gladka MM; Asselbergs FW; Vink A; Harakalova M; Bossu A; van Veen TAB; Boogerd CJ; van Rooij E
    Cardiovasc Res; 2021 May; 117(6):1532-1545. PubMed ID: 32717063
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The anti-cancer drug dabrafenib is not cardiotoxic and inhibits cardiac remodelling and fibrosis in a murine model of hypertension.
    Meijles DN; Cull JJ; Cooper STE; Markou T; Hardyman MA; Fuller SJ; Alharbi HO; Haines ZHR; Alcantara-Alonso V; Glennon PE; Sheppard MN; Sugden PH; Clerk A
    Clin Sci (Lond); 2021 Jul; 135(14):1631-1647. PubMed ID: 34296750
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuron-derived orphan receptor-1 modulates cardiac gene expression and exacerbates angiotensin II-induced cardiac hypertrophy.
    Cañes L; Martí-Pàmies I; Ballester-Servera C; Herraiz-Martínez A; Alonso J; Galán M; Nistal JF; Muniesa P; Osada J; Hove-Madsen L; Rodríguez C; Martínez-González J
    Clin Sci (Lond); 2020 Feb; 134(3):359-377. PubMed ID: 31985010
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NF-kappaB activation is required for adaptive cardiac hypertrophy.
    Zelarayan L; Renger A; Noack C; Zafiriou MP; Gehrke C; van der Nagel R; Dietz R; de Windt L; Bergmann MW
    Cardiovasc Res; 2009 Dec; 84(3):416-24. PubMed ID: 19620128
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiac anti-remodelling effect of aerobic training is associated with a reduction in the calcineurin/NFAT signalling pathway in heart failure mice.
    Oliveira RS; Ferreira JC; Gomes ER; Paixão NA; Rolim NP; Medeiros A; Guatimosim S; Brum PC
    J Physiol; 2009 Aug; 587(Pt 15):3899-910. PubMed ID: 19505981
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FHL2 prevents cardiac hypertrophy in mice with cardiac-specific deletion of ROCK2.
    Okamoto R; Li Y; Noma K; Hiroi Y; Liu PY; Taniguchi M; Ito M; Liao JK
    FASEB J; 2013 Apr; 27(4):1439-49. PubMed ID: 23271052
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.